3031-3040 of 4473 results
Abolition of the 457 visa program - what this means for employers
The Turnbull Government announced on 18 April 2017 that it is abolishing its 457 visa program and replacing it with a new Temporary Skill Shortage visa program Implementation of the visa reforms commenced immediately and are to be completed in March 2018 Partner Veronica Siow provides a snapshot of ...
Franchisors and holding companies liable under Vulnerable Workers Bill
The Federal Government has introduced a Bill that will make franchisors liable for breaches of employment law by franchisees Partner Simon Dewberry and Managing Associate Andrew Stirling report ...
Contract Law Update 2016
When is a person bound by their e-signature When does a breach of contract constitute a repudiation of that contract When does an exchange of correspondence give rise to a binding contract What is the latest on penalties These were some of the contract law issues considered by appellate courts ...
The efficacy of e-signatures
Allens has adopted e-signature using DocuSign as a service to clients. Senior Finance Counsel Diccon Loxton has written an article in two parts that examines the efficacy of e-signatures. ...
Financial Services Class Actions
Our class actions team recently published our Class Action Risk 2016 report The objective of the report is to look behind the headlines and hype that often surrounds class actions to provide a more holistic and objective assessment of class action risk for our clients This is particularly important ...
Productivity Commission report into superannuation system bodes well for the future
At first glance the recent Productivity Commission Draft Report on How to Assess the Competitiveness and Efficiency of the Superannuation System August 2016 could be dismissed as nothing more than a procedural step along the road to the ultimate goal as recommended by the FSI of developing an ...
What's in a (biosimilar) name?
Because biosimilars and their reference biologic medicine are not identical whether compared to each other or even between biosimilars it is important to know which product has been used ...
Protecting investment in biologic medicines - biological medicines, biosimilars and the challenges they pose
This series of articles is directed towards the part of biotech that is pharmaceutical rather than diagnostic or bioengineering technologies and in particular towards biologic medicines ...
Implications for government acquiring agencies under NSW land acquisition reform
This insight examines the key changes to the NSW Governments' announcement to its intention to reform the land acquisition process in New South Wales. ...
Not better late - the Prime Trust appeal judgment
The main Prime Trust appeal judgement is relatively well known but a trusts responsible entities and their officers should look at what the appeal court had to say on other related matters ...